Epidemiological Study of Vulvovaginal Candidiases Strain Types and Risk Factors Among Gynecological Outpatients in China
Launched by BEIJING TSINGHUA CHANG GUNG HOSPITAL · Dec 28, 2023
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is an important study looking into a condition called Vulvovaginal Candidiasis, which is a type of yeast infection affecting women. The researchers want to understand the different strains of the infection that are present in China and identify the risk factors that may make women more likely to get it. They will also analyze how resistant these strains are to common treatments. The study is not yet recruiting participants, but when it does, it will focus on female gynecological outpatients aged 18 and older who have been diagnosed with Vulvovaginal Candidiasis and can provide informed consent.
To participate, women must not have used antifungal medications in the past week and should not have any conditions that would prevent them from being included in the study. Participants can expect to undergo assessments related to their condition, and their involvement will help researchers gather valuable information that could improve understanding and treatment of this common infection in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Outpatients of gynecology
- • 2. Age≧18 years
- • 3. Signed informed consent form voluntarily
- • 4. With diagnosis and symptomatology of Vulvovaginal Candidiasis (all types of Vulvovaginal Candidiasis can be included)
- • 5. History of sexual life
- Exclusion Criteria:
- • 1. Antifungal medication was used within 7 days (oral or topical)
- • 2. With contraindications of vaginal sampling
- • 3. Other conditions deemed unsuitable for inclusion by clinicians
About Beijing Tsinghua Chang Gung Hospital
Beijing Tsinghua Chang Gung Hospital is a leading medical institution in China, known for its commitment to advancing healthcare through innovative clinical research and trial sponsorship. Affiliated with Tsinghua University and Chang Gung Memorial Hospital, the facility combines cutting-edge medical technology with a robust academic framework to facilitate high-quality clinical trials. The hospital specializes in a range of therapeutic areas, focusing on improving patient outcomes and contributing to global medical knowledge. With a multidisciplinary team of experts, Beijing Tsinghua Chang Gung Hospital is dedicated to fostering collaborations that enhance the efficacy and safety of new treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported